Loading company…
Sonablate develops image-guided ultrasound systems for non-invasive treatment, including prostate tissue ablation.
Founded in 2004 and based in North Carolina, Sonablate develops image-guided therapeutic ultrasound systems, including the FDA-cleared Sonablate HIFU System for prostate tissue ablation. Its portfolio also includes HIFU, LIFU, LOFU, Sonatherm, and SonaTripsy technologies. In August 2026, it raised USD 200 million in venture funding from Eleven Ventures to expand globally and advance AI-assisted precision medicine applications.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in